Brian Roselauf brings 16 years of engineering product development experience and a track record of bringing concepts to commercialization within large publicly traded companies as well as startups. He also has an extensive background in developing implantable prosthetic devices through his professional experiences with Edwards Lifesciences, Arbor Surgical Technologies, Endologix, CardiAQ, and HighLife Medical. Notably, Brian worked with Covidien Neurovascular which was purchased by Medtronic for $43 billion, CardiAQ, which was later purchased by Edwards Lifesciences for $400 million, and HighLife Medical, which recently received $36 million in Series B funding. Brian’s breadth technical skills in a multitude of engineering disciplines, expertise in project management, and leadership experiences will drive technology development at HJLI. Brian has an Executive MBA from UCLA’s Anderson School of Management, an M.S. is Mechanical Engineering from California State Polytechnic University Pomona, and a B.S. in Bioengineering from the University of California San Diego. Brian is also a health and wellness advocate and a 10-time IRONMAN finisher.
Current role
Director Of Research And Development at Clean Seed Capital Group
Director Of Research And Development - Grills - Retired at Napoleon
Director Of Research And Development at Convergent Genomics
Senior Director Of Research And Development at Mekonos
Director Of Research And Development (biocides & Agriculture) at TyraTech, Inc.
Access the worlds's biggest network of public org charts
Learn more